Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2024

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory

Inventory consisted of the following:

	June 30,		December 31,
(in thousands)	2024		2023
Raw materials	$	9,525	$	11,257
Work-in-process		22,802		15,670
Finished goods		4,337		13,810
Total inventory	$	36,664	$	40,737

Schedule Of Other Accrued Liabilities

Other accrued liabilities consisted of the following:

	June 30,		December 31,
(in thousands)	2024		2023
Accrued contract manufacturing expenses	$	1,052	$	1,966
Accrued clinical and research expenses		460		776
Accrued professional services		5,988		8,876
Current portion of lease liabilities		1,451		1,207
Current portion of deferred royalty obligations		663		—
Royalty obligation payable		2,646		1,928
Accrued license fees and royalties		1,465		1,575
Other		3,408		3,370
Total other accrued liabilities	$	17,133	$	19,698

Schedule of Other Long-term Liabilities

Other long-term liabilities consisted of the following:

	June 30,		December 31,
(in thousands)	2024		2023
Long-term portion of deferred royalty obligation	$	69,868	$	69,876
Long-term portion of lease liabilities		1,983	$	1,635
Contingent value rights liability		214		359
Total other long-term liabilities	$	72,065	$	71,870